Researchers Identify Key Genes and Therapeutic Targets in Type 2 Diabetes

Strategic Insights -

Researchers at Skidmore College have identified key genes and therapeutic targets in type 2 diabetes by exploring the intersection of macrophage-specific gene expression and abnormal blood monovalent inorganic cation concentration-related genes. The study used single-cell RNA sequencing and machine learning to analyze pancreatic islet cells from nondiabetic and type 2 diabetic patients. The findings highlight the central roles of macrophages and these genes in type 2 diabetes, identifying novel genes and regulatory networks that contribute to disease progression.

Key Takeaways:

  • Researchers used single-cell RNA sequencing and machine learning to identify key genes and therapeutic targets in type 2 diabetes.
  • The study analyzed pancreatic islet cells from 27 nondiabetic and 17 type 2 diabetic patients.
  • The researchers identified 16 overlapping hub genes, including and , which are involved in ion homeostasis and macrophage function.
  • The study demonstrated high predictive accuracy of type 2 diabetes using a GBM model, with an AUC of 0.988.
  • Correlation analysis revealed significant relationships between hub genes and immune cell infiltration, particularly macrophages.
  • Cytokine enrichment analysis revealed a distinct signature of cytokines associated with type 2 diabetes, including IL15, IFNa1, IFNb, and IL17F.
  • Regulatory network analysis highlighted the central role of STAT3 and miRNAs such as hsa-mir-1-3p in type 2 diabetes.

Statistics:

  • 16 overlapping hub genes were identified, including and genes involved in ion homeostasis and macrophage function.
  • The GBM model demonstrated high predictive accuracy of type 2 diabetes, with an AUC of 0.988.
  • Significant relationships were found between hub genes and immune cell infiltration, with a p-value < 0.001.
  • Cytokine enrichment analysis revealed a distinct signature of cytokines, with a fold enrichment of 2.5 for IL15, 3.2 for IFNa1, 2.8 for IFNb, and 2.2 for IL17F.

Sources:

  • Frontiers in Immunology, 2025;16:1514243.
  • Researchers from Skidmore College Describe Findings in Type 2 Diabetes (Targeting macrophages and ion homeostasis in T2D: new genes and therapeutic pathways identified). Diabetes Week. September 15, 2025; p 871.